142 related articles for article (PubMed ID: 25645675)
41. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
42. PGE
Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
[TBL] [Abstract][Full Text] [Related]
43. Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains.
Chalhoub N; Zhu G; Zhu X; Baker SJ
Genes Dev; 2009 Jul; 23(14):1619-24. PubMed ID: 19605683
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
45. Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes.
Rubio M; Avitabile D; Fischer K; Emmanuel G; Gude N; Miyamoto S; Mishra S; Schaefer EM; Brown JH; Sussman MA
J Mol Cell Cardiol; 2009 Jul; 47(1):96-103. PubMed ID: 19269295
[TBL] [Abstract][Full Text] [Related]
46. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
[TBL] [Abstract][Full Text] [Related]
47. PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.
Yang C; Huang X; Liu H; Xiao F; Wei J; You L; Qian W
Oncotarget; 2017 Jun; 8(24):39185-39197. PubMed ID: 28402933
[TBL] [Abstract][Full Text] [Related]
48. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).
Mishra RK; Scaife JE; Harb Z; Gray BC; Djukanovic R; Dent G
Allergy; 2005 Sep; 60(9):1204-7. PubMed ID: 16076309
[TBL] [Abstract][Full Text] [Related]
49. Small-molecule inhibitors of PDK1.
Peifer C; Alessi DR
ChemMedChem; 2008 Dec; 3(12):1810-38. PubMed ID: 18972468
[TBL] [Abstract][Full Text] [Related]
50. Prostaglandin E
Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
Front Immunol; 2018; 9():501. PubMed ID: 29593738
[TBL] [Abstract][Full Text] [Related]
51. T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.
Chaudhuri S; Singh MK; Bhattacharya D; Datta A; Hazra I; Mondal S; Faruk Sk Md O; Ronsard L; Ghosh TK; Chaudhuri S
J Cell Physiol; 2018 Feb; 233(2):759-770. PubMed ID: 28608562
[TBL] [Abstract][Full Text] [Related]
52. Decreased MAPK- and PGE2-dependent IL-11 production in Gialpha2-/- colonic myofibroblasts.
Hoang B; Trinh A; Birnbaumer L; Edwards RA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1511-9. PubMed ID: 17332478
[TBL] [Abstract][Full Text] [Related]
53. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
[TBL] [Abstract][Full Text] [Related]
54. PDK1-AKT signaling pathway regulates the expression and function of cardiac hyperpolarization-activated cyclic nucleotide-modulated channels.
Han Z; Wu X; Gao Y; Liu X; Bai J; Gu R; Lan R; Xu B; Xu W
Life Sci; 2020 Jun; 250():117546. PubMed ID: 32184125
[TBL] [Abstract][Full Text] [Related]
55. Characterization of PGE2 receptor subtypes in human eosinophils.
Mita H; Hasegawa M; Higashi N; Akiyama K
J Allergy Clin Immunol; 2002 Sep; 110(3):457-9. PubMed ID: 12209094
[TBL] [Abstract][Full Text] [Related]
56. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes.
Nishitani K; Ito H; Hiramitsu T; Tsutsumi R; Tanida S; Kitaori T; Yoshitomi H; Kobayashi M; Nakamura T
J Cell Biochem; 2010 Feb; 109(2):425-33. PubMed ID: 19998410
[TBL] [Abstract][Full Text] [Related]
57. PPARĪ³ as an E3 Ubiquitin-Ligase Impedes Phosphate-Stat6 Stability and Promotes Prostaglandins E
Wu J; Wang Y; Zhou Y; Wang Y; Sun X; Zhao Y; Guan Y; Zhang Y; Wang W
Front Immunol; 2020; 11():1224. PubMed ID: 32636842
[TBL] [Abstract][Full Text] [Related]
58. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
59. Opposing effects of prostaglandin E
Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
[TBL] [Abstract][Full Text] [Related]
60. Dissociation between the translocation and the activation of Akt in fMLP-stimulated human neutrophils--effect of prostaglandin E2.
Burelout C; Naccache PH; Bourgoin SG
J Leukoc Biol; 2007 Jun; 81(6):1523-34. PubMed ID: 17339610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]